[Lipid lowering therapy for primary prevention of coronary heart disease--contra lipid lowering therapy].
With regard to total mortality rates, there is no benefit of primary prevention by lipid lowering. For the prevention of coronary events the use of statins seems to be effective in high risk individuals (risk of a coronary event > 3.0% per year) above a certain serum cholesterol level.
Berger
M
M
Klinik für Stoffwechselkrankheiten und Ernährung, WHO Collaborating Center for Diabetes, Heinrich-Heine-Universität Düsseldorf.
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D016896:Treatment Outcome
D000960:Hypolipidemic Agents; D002784:Cholesterol
Lipidsenkende Therapie zur Primärprävention der koronaren Herzkrankheit--Contra lipidsenkende Therapie.